High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.
Coronary heart disease (CHD) is the major cause of death in the developed world and screening for conventional cardiovascular risk factors fails to identify more than 50% of the individuals who will present with acute coronary syndromes. Chronic inflammation appears to play a significant role in the initiation and development of atherosclerosis. Recent investigations have shown an association between inflammatory markers such as C-reactive protein (CRP) and CHD. These markers have proven useful as prognostic indicators in acute coronary syndromes and in predicting future coronary events in apparently healthy men and women. The availability of high sensitivity CRP (hs-CRP) assays has been crucial in exploring the role of this acute phase reactant in primary prevention settings. In this review, we discuss the evidence associating these inflammatory markers, especially CRP, with the pathogenesis of atherosclerosis and acute coronary syndromes, and we address the mechanism of risk as well as the clinical utility of this marker.
Benzaquen
Laura R
LR
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Yu
Harry
H
Rifai
Nader
N
D015415:Biomarkers; D002097:C-Reactive Protein / Q000032:analysis*; D003327:Coronary Disease / Q000175:diagnosis* / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D018570:Risk Assessment; D012680:Sensitivity and Specificity
D015415:Biomarkers; D002097:C-Reactive Protein